Pemetrexed: A Review of its Use in Malignant Pleural Mesothelioma and Non-Small-Cell Lung Cancer

Author： Dean M. Robinson   Gillian M. Keating   Antona J. Wagstaff  

Publisher： Adis International

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.3, Iss.6, 2004-01, pp. : 387-399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The place of pemetrexed in the management of non-small-cell lung cancer patients

By Tomasini Pascale   Greillier Laurent   Khobta Nataliya   Barlesi Fabrice  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 3, 2013-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

Clinical observation of pemetrexed on advanced non-small-cell lung cancer

By Zheng Yongfa   Ge Wei   Zhang Ling   Zhao Zhenyu   Jie Fangfang  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 3, 2011-03 ,pp. : 140-143

Springer Publishing Company

Access to resources Recommend Favorite

Pemetrexed in heavily pretreated non-small-cell lung cancer patients: case report and review of the literature

By Tartarone Alfredo  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1937-1940

Future Medicine

Access to resources Recommend Favorite

Role of Pemetrexed in Non-Small Cell Lung Cancer

By Longo-Sorbello Giuseppe   Chen Bobin   Budak-Alpdogan Tulin   Bertino Joseph  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 59-66

Informa Healthcare

Access to resources Recommend Favorite

Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis

By Liu Yu   Yin Tie-Jun   Zhou Rong   Zhou Si   Fan Liang   Zhang Rong-Ge  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1125-1132

Springer Publishing Company

Access to resources Recommend Favorite